Adamis Pharmaceuticals CEO Dennis Carlo's 2018 pay falls 41% to $1.5M
Adamis Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: June 25, 2019
Adamis Pharmaceuticals reported fiscal year 2018 executive compensation information on June 25, 2019.
In 2018, four executives at Adamis Pharmaceuticals received on average a compensation package of $1.1M, a 40% decrease compared to previous year.
Average pay of disclosed executives at Adamis Pharmaceuticals
Dennis J. Carlo, Chief Executive Officer, received $1.5M in total, which decreased by 41% compared to 2017. 42% of Carlo's compensation, or $635K, was in salary. Carlo also received $343K in non-equity incentive plan, $262K in option awards, $236K in stock awards, as well as $28K in other compensation.
Robert O. Hopkins, Chief Financial Officer, received a compensation package of $969K, which decreased by 26% compared to previous year. 40% of the compensation package, or $386K, was in salary.
David J. Marguglio, Senior Vice President, Chief Business Officer, earned $967K in 2018, a 34% decrease compared to previous year.
Ronald B. Moss, Chief Medical Officer, received $832K in 2018.
Related executives
You may also like
Source: SEC filing on June 25, 2019.